Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
AOD-9604, thanks to its mechanism (lipolysis directly from adipose tissue without effect on muscle cells), may help steer the weight reduction toward the fat component
As ongoing TRIUMPH trials unfold, Eli Lilly anticipates a possible FDA submission in the coming years, hinting at a 2028 release
Second, it argues against a pure placebo effect, because placebo responses tend to diminish more gradually
Obesity / Chronic Weight Management 5.5.1
As of mid-2025, retatrutide has not received marketing authorisation in the United Kingdom, the European Union, or the United States
US$ 29.27
US$ 23.07
US$ 25.19
US$ 23.39
